BN Agrochem: revenue triples YoY to ₹750 Cr, adjusted PAT jumps past a tax-inflated base
PAT -53.84% YoY · revenue +246.46% · margins expanding
₹750.05 Cr
+246.46% YoY
₹8.27 Cr
-53.84% YoY
1.1%
-7.2pp YoY
₹0.85
On a consolidated basis — primary over standalone, where revenue (₹281.07 Cr) and PAT (₹1.88 Cr) are materially smaller, confirming most of the scale-up sits in subsidiaries — BN Agrochem (formerly BN Holdings) reported Q2 FY27 revenue of ₹750.05 Cr, up 246% YoY from ₹216.49 Cr and 191% QoQ from ₹257.61 Cr. Reported PAT was ₹8.27 Cr, down 53.8% YoY from ₹17.92 Cr but up 177.6% QoQ from ₹2.98 Cr, with EPS of ₹0.85 against ₹1.83 a year ago and ₹0.30 last quarter.
Q2 FY-2027 vs prior quarters
The YoY profit comparison is distorted by the tax line rather than operations: last year's ₹17.92 Cr PAT came almost entirely from a one-off ₹17.35 Cr deferred-tax credit sitting on a pre-tax profit of just ₹0.56 Cr. This quarter's tax charge of ₹2.01 Cr is a normalised ~19.5% rate on a pre-tax profit of ₹10.28 Cr — roughly 18x the year-ago underlying base — so adjusted PAT growth is around +1,365%, a turnaround from a business that was barely profitable at the operating level a year ago to one generating real profit at much larger scale. Margin-wise, Cost of Material Consumed/Construction & Project Cost was ₹735.36 Cr, 98% of revenue, which is why consolidated NPM is still thin at 1.10% (down from 8.28% YoY on the tax-base artifact, flat versus 1.16% last quarter); OPM (EBITDA margin), the cleaner operating read, actually improved to 1.48% from 0.59% YoY, though it eased from 2.29% QoQ as the revenue mix scaled.
The stock went into the print at ₹160.45, down 1.6% over the past month of trading.
For context: PAT has now risen for 2 consecutive quarters.
There is no analyst coverage of this stock (confirmed via web search — zero active analyst estimates/recommendations), so the print cannot be benchmarked against street consensus, and there is no formal management guidance or prior concall on record either in our data or found online, so vsGuidance is unknown rather than inferred. Management has not issued a separate press-release commentary beyond the standard BSE outcome-of-board-meeting disclosure. The quarter's corporate calendar included an income-tax search that concluded October 28, 2026 with no seizure — a de-risking event unconnected to these P&L numbers — alongside an NCLT-granted 90-day extension (October 2) for the pending group amalgamation, and continuing steps toward a 1:10 stock split (the October 22 EOGM was adjourned for lack of quorum, yet a record date was subsequently fixed November 2).
W1
Whether the ~1.1-1.5% consolidated margin holds as revenue scales further — Cost of Material was 98% of revenue this quarter.
W2
Outcome of the NCLT-extended amalgamation process, due within 90 days of the October 2, 2026 extension.
W3
Completion of the 1:10 stock split given the October 22 EOGM's quorum failure, despite the November 2 record-date announcement.
Figures converted from ₹ Lacs (source) to ₹ Cr; both statements are clean, legible limited-review (unaudited) tables with arithmetic ties exactly. Year-ago quarter's ₹17.92 Cr consolidated PAT was driven almost entirely by a one-off ₹17.35 Cr deferred-tax credit on a pre-tax profit of only ₹0.56 Cr, making the raw YoY PAT comparison misleading; no exceptional items in the current quarter.